ATP7A and non-small cell lung carcinoma: It is critical to understand the molecular mechanisms of exhibiting enhanced inhibitory effects on NSCLC cells by combination of mTOR and Mnk inhibitors, and which will help us to develop new therapy strategies to overcome resistance in mTOR-targeted cancer therapy.